Article · 22 Oct 2026
Short communicationPublished 22 Feb 2022
Neointima Development in Pulmonary Arterial Hypertension: A Possible Mechanism
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pulmonary arterial hypertension (PAH) is a significant complication of a variety of systemic disorders, such as cardiac, inflammatory, and autoimmune diseases. Endothelial instability and dysfunction are important in the onset and course of the disease. Although current medicine has improved quality of life, the underlying vascular disease continues to worsen, and the survival rate has not considerably improved. Impaired vascular relaxation response, medial hypertrophy, and increased pulmonary pressure are the predominant pathogenic alterations; subsequent neointimal development resulting in disease irreversibility. The loss of endothelial Caveolin-1 (cav-1), a membrane protein, has been linked to the reciprocal activation of proliferative pathways and the onset of PAH. Endothelial cell and endothelial cav-1 disruption is followed by increased expression of cav-1 in smooth muscle cells.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Clinical Skills.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Skills
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “William Sam”
- BylineArticles whose byline prints “Rebecca Davis”